查找临床试验
已按「荨麻疹」检索，对应国际通用词 chronic urticaria
共找到 12 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 11:18，每 5 分钟自动同步Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)
Canada
年龄 18 Years – 80 Years
Akros Pharma Inc.
Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
United States
年龄 18 Years – 120 Years
National Institute of Allergy and Infectious Diseases (NIAID)
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
France
年龄 18 Years – 不限
Celltrion HealthCare France
Analysis of the Role of IgE Proteoforms in Health and Disease
Belgium
年龄 18 Years – 不限
KU Leuven
Remibrutinib in Real-world Clinical Practice - a US Sub-study
United States
年龄 18 Years – 100 Years
Novartis Pharmaceuticals
Deployment o the Multidisciplinary Prospective Cohort Imminent
France
年龄 18 Years – 不限
University Hospital, Lille
Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)
United States
年龄 不限 – 99 Years
National Institute of Allergy and Infectious Diseases (NIAID)
Deep Phenotyping of CIndU
Netherlands
年龄 18 Years – 不限
Centre for Human Drug Research, Netherlands
A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
Germany
年龄 18 Years – 75 Years
Granular Therapeutics Limited
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
United States
年龄 18 Years – 不限
Novartis Pharmaceuticals
Ilaris NIS in Korea
South Korea
年龄 2 Years – 100 Years
Novartis Pharmaceuticals
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
Bulgaria、China、Poland、South Korea
年龄 18 Years – 75 Years
Yuhan Corporation